Kai Licha
Directeur Général chez FEW Chemicals GmbH
Profil
Kai Licha is currently the Co-Managing Director at FEW Chemicals GmbH and a Member of the Chemical Faculty at Freie Universität Berlin.
Previously, he worked as a Principal at Bayer Schering Pharma AG and as the Head of Drug Research at mivenion GmbH.
He holds a doctorate degree from the Technical University of Berlin, which he received in 1993.
Postes actifs de Kai Licha
| Sociétés | Poste | Début |
|---|---|---|
| Freie Universität Berlin | Corporate Officer/Principal | - |
FEW Chemicals GmbH
 FEW Chemicals GmbH Chemicals: Major DiversifiedProcess Industries FEW Chemicals GmbH develops and produces specialty chemicals. Its products find application as functional dyes in cd-r, computer-to-plate as fluorescence marker, laser dyes, filters, nir absorbers or as nano-varnish and additives for surface refinement services. The company was founded in 1997 and is headquartered in Bitterfeld-Wolfen, Germany. | Directeur Général | 01/01/2018 |
Anciens postes connus de Kai Licha
| Sociétés | Poste | Fin |
|---|---|---|
| Bayer Schering Pharma AG | Corporate Officer/Principal | - |
mivenion GmbH
 mivenion GmbH Medical SpecialtiesHealth Technology mivenion GmbH offers personalized medical solutions for patients with inflammatory and autoimmune diseases. Its flagship product, Xiralite, enables the Rheumascan procedure that provides integrated solution for patients with inflammatory diseases in the hands. The company was founded by Michael Schirner and Malte Bahner in 2007 and is headquartered in Berlin, Germany. | Directeur Technique/Scientifique/R&D | - |
Formation de Kai Licha
| Technical University of Berlin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| Bayer Schering Pharma AG | Health Technology |
mivenion GmbH
mivenion GmbH Medical SpecialtiesHealth Technology mivenion GmbH offers personalized medical solutions for patients with inflammatory and autoimmune diseases. Its flagship product, Xiralite, enables the Rheumascan procedure that provides integrated solution for patients with inflammatory diseases in the hands. The company was founded by Michael Schirner and Malte Bahner in 2007 and is headquartered in Berlin, Germany. | Health Technology |
FEW Chemicals GmbH
FEW Chemicals GmbH Chemicals: Major DiversifiedProcess Industries FEW Chemicals GmbH develops and produces specialty chemicals. Its products find application as functional dyes in cd-r, computer-to-plate as fluorescence marker, laser dyes, filters, nir absorbers or as nano-varnish and additives for surface refinement services. The company was founded in 1997 and is headquartered in Bitterfeld-Wolfen, Germany. | Process Industries |
